Cytomegalovirus (CMV) is one of the most important pathogens following solid-organ
transplantation, and effective prevention of CMV infection is a priority. The long-term control …

The introduction and combination of more-potent immunosuppressive regimens, and the
increased transplantation of organs into more severely ill patients, have again placed …

As the most prevalent pathogen among transplant patients, cytomegalovirus (CMV) affects
up to three‐quarters of all solid organ transplant recipients. While we have made great …

Transplant recipients receiving immunosuppressive therapy are at increased risk of active
cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as …

Background: Cytomegalovirus (CMV) infection of solid organ transplant (SOT) recipients
causes both ''direct''and ''indirect''effects including allograft rejection, decreased graft and …

Despite advances in prevention, cytomegalovirus (CMV) recurrence is an important
challenge in high‐risk organ recipients. The present study prospectively evaluates the …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Despite remarkable improvements in its diagnosis, prevention, and treatment,
cytomegalovirus (CMV) remains the single most important pathogen after solid organ …

Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …